E2F7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Comparison | Statistical significance |
Normal-vs-Primary | 1.60982338570648E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.51020000008317E-07 |
Normal-vs-Stage2 |
5.362300E-02 |
Normal-vs-Stage3 |
2.589900E-04 |
Normal-vs-Stage4 |
1.305610E-02 |
Stage1-vs-Stage2 |
3.434400E-01 |
Stage1-vs-Stage3 |
6.398100E-03 |
Stage1-vs-Stage4 |
9.644300E-02 |
Stage2-vs-Stage3 |
2.135800E-01 |
Stage2-vs-Stage4 |
8.710200E-01 |
Stage3-vs-Stage4 |
2.222600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.99639979495225E-10 |
Normal-vs-AfricanAmerican |
5.043900E-04 |
Normal-vs-Asian |
7.076400E-03 |
Caucasian-vs-AfricanAmerican |
8.772000E-01 |
Caucasian-vs-Asian |
3.963400E-01 |
AfricanAmerican-vs-Asian |
3.371400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.41729985922734E-11 |
Normal-vs-Female |
1.53430000005006E-06 |
Male-vs-Female |
4.141000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.162720E-04 |
Normal-vs-Extreme_Weight |
4.5861003883374E-10 |
Normal-vs-Obese |
4.209200E-04 |
Normal-vs-Extreme_Obese |
4.592300E-02 |
Normal_Weight-vs-Extreme_Weight |
5.819600E-02 |
Normal_Weight-vs-Obese |
4.097600E-01 |
Normal_Weight-vs-Extreme_Obese |
4.237800E-03 |
Extreme_Weight-vs-Obese |
2.764400E-02 |
Extreme_Weight-vs-Extreme_Obese |
3.075900E-02 |
Obese-vs-Extreme_Obese |
4.035700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.163510E-02 |
Normal-vs-Age(41-60Yrs) |
1.82189818787037E-11 |
Normal-vs-Age(61-80Yrs) |
2.21330000005349E-06 |
Normal-vs-Age(81-100Yrs) |
1.729860E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.694400E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.962100E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.438000E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.673800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.038310E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.230200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
6.33279999551206E-08 |
Normal-VS-Type2 PRCC |
1.35710000015443E-07 |
Normal-VS-KIRP CIMP |
1.860750E-03 |
Normal-VS-Unclassified PRCC |
7.54040000000566E-05 |
Type1 PRCC-VS-Type2 PRCC |
9.166400E-01 |
Type1 PRCC-VS-KIRP CIMP |
3.604000E-03 |
Type1 PRCC-VS-Unclassified PRCC |
7.216200E-02 |
Type2 PRCC-VS-KIRP CIMP |
3.675300E-03 |
Type2 PRCC-VS-Unclassified PRCC |
8.879900E-02 |
KIRP CIMP-VS-Unclassified PRCC |
6.381000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.70649999995132E-06 |
Normal-vs-N1 |
8.606200E-04 |
Normal-vs-N2 |
1.843230E-01 |
N0-vs-N1 |
8.763200E-03 |
N0-vs-N2 |
1.470990E-01 |
N1-vs-N2 |
4.733800E-01 |
|
|